PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Microbiology, \'G. Gennimatas\' General Hospital, Thessaloniki, Greece.\', \'Laboratory of Biometry, University of Thessaly, Phytokou Str, 38446, Nea Ionia, Magnesia, Greece.\', \'University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.\', \'Department of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.\', \'Committee of Hospital Infections, \'G. Gennimatas\' General Hospital, Thessaloniki, Greece.\', \'Department of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. papazisg@auth.gr.\', \'Clinical Trials Unit, Special Unit for Biomedical Research and Education, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. papazisg@auth.gr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40520-021-01997-7
?:hasPublicationType
?:journal
  • Aging clinical and experimental research
is ?:pmid of
?:pmid
?:pmid
  • 34633648
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in elderly people over 85 years of age in Greece: the GREVAXIMO study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all